Opioid overdoses killed 47,000 Americans in 2017 — more than gun violence. Many fewer would have died if they’d been treated with the life-saving drug naloxone, also called Narcan.
Articles on Opioid overdose
Displaying 21 - 27 of 27 articles
Cannabis legalization in Canada is a public health strategy. Let’s harness this opportunity to understand how cannabis could fit into a multi-faceted opioid prevention and response strategy.
A scholar explains why there is no one answer. Some pain is devastating, and sometimes such pain responds well to opioids. On the other hand, there is evidence that some physicians overprescribe.
High fructose corn syrup in food and drinks has long been linked to rising rates of child and teen obesity. New evidence suggests it increases the risks of opioid addiction and overdose too.
How can we fight the opioid epidemic? Redesign the drugs, rethink how we assess patients and mandate prescription monitoring.
HIV, STIs and other dangerous infections are feeding off of the opioid epidemic, creating an even more complicated threat to public health.
Naloxone is used as an “antidote” for opioid overdose which includes heroin, and opioid pain medicines such as morphine, fentanyl and codeine.
Top contributors
-
Professor of Emergency Medicine, UMass Chan Medical School
-
Professor of Criminology, University of South Wales
-
Professor and Deputy Director, Monash Addiction Research Centre, Monash University
-
Assistant Professor Department of Health Services Policy and Management; Adjunct Professor Department of Clinical Pharmacy and Outcomes Sciences; Principal Investigator William Jennings Bryan Dorn Veterans Affairs Medical Center, University of South Carolina
-
Assistant Professor of Public Health and Community Medicine, Tufts University
-
Research Scientist, BC Centre on Substance Use and Assistant Professor in the Division of AIDS, Department of Medicine, University of British Columbia
-
Professor and Director, National Drug Research Institute, Curtin University
-
Professor of Pharmacy, Wayne State University
-
Director of the Master of Bioethics degree program at the Berman Institute of Bioethics, Johns Hopkins University
-
Professor of Psychology, University of Guelph
-
Associate Professor of Pharmacology, University of Arizona
-
Associate Professor of Pharmacy and Therapeutics, University of Pittsburgh
-
Professor of Pharmacy and Therapeutics, University of Pittsburgh
-
Researcher of Geography, Penn State
-
Chair in Clinical Pharmacology and Therapeutics, University of Hertfordshire